Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: Comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO

Korean Journal of Radiology

Volumn 8, Issue 5, 2007, Pages 365-371

  Song, Miyeoun ^a   Woo, Kyung Moon ^a   Kim, Yunhee ^a   Lim, Dongyeol ^b   Song, In Chan ^a   Yoon, Byung Woo ^a  

^a Seoul National University Hospital   (South Korea)

^b Sejong University   (South Korea)

Author keywords

Human neural stem cell; Iron oxide nanoparticles; Magnetic resonance (MR)

Indexed keywords

CONTRAST MEDIUM; CROSS LINKING REAGENT; FERRIC ION; FERRIC OXIDE; IRON; MAGNETITE; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; NANOPARTICLE; OXIDE; POLYLYSINE; SUPERPARAMAGNETIC IRON OXIDE; TRANSACTIVATOR PROTEIN;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GENETIC TRANSFECTION; HUMAN; IMAGE QUALITY; METABOLISM; METHODOLOGY; NEURAL TUBE; NUCLEAR MAGNETIC RESONANCE IMAGING; STAINING; STEM CELL; SYNTHESIS; TIME;

CELLS, CULTURED; CONTRAST MEDIA; CROSS-LINKING REAGENTS; FERRIC COMPOUNDS; FERROSOFERRIC OXIDE; GENE PRODUCTS, TAT; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NEURAL TUBE; OXIDES; PHANTOMS, IMAGING; POLYLYSINE; SPECTROPHOTOMETRY, ATOMIC; STAINING AND LABELING; STEM CELLS; TIME FACTORS; TRANSFECTION;

EID: 36248959828     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2007.8.5.365     Document Type: Article

References (25)

1. Kim SU. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 2004;24:159-171
2. Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 2004;10:S42-50
3. Bulte JW, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab 2002;22:899-907
4. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319-2331
5. Jendelová P, Herynek V, Urdzikova L, Glogarova K, Kroupová J, Andersson B, et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 2004;76:232-243
6. Daldrup-Link HE, Rudelius MR, Piontek G, Metz S, Brauer R, Debus G, et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005;234:197-205
7. Wunderbaldinger P, Josephson L, Weissleder R. Crosslinked Iron Oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad Radiol 2002;9:S304-S306
8. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR Jr. Efficient transfer of genetic material into mammalian cells using starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA 1996;93:4897-4902
9. Tang MX, Redemann CT, Szoka FC Jr. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 1996;7:703-714
10. Plank C, Mechtler K, Szoka FC Jr, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Human Gene Ther 1996;7:1437-1446
11. DeLong R, Stephenson K, Loftus T, Fisher M, Alahari S, Nolting A, et al. Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery. J Pharm Sci 1997;86:762-764
12. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-tat peptide conjugate. Bioconjug Chem 1999;10:186-191
13. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotechnol 2000;18:410-414
14. Zhao M, Kircher MF, Josephson L, Weissleder R. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem 2002;13:840-844
15. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988;55:1189-1193
16. Arbab AS, Yocum GT, Wilson LB, Parwana A, Jordan EK, Kalish H, et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 2004;3:24-32
17. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003;229:838-846
18. Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, et al. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 2005;235:155-161
19. Montet-Abou K, Montet X, Weissleder R, Josephson L. Transfection agent induced nanoparticle cell loading. Mol Imaging 2005;4:165-171
20. Wunderbaldinger P, Josephson L, Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem 2002;13:264-268
21. Weissleder R, Cheng HC, Bogdanova A, Bogdanova A Jr. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997;7:258-263
22. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480-487
23. Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF. Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling of with ferumoxides. Blood 2004;104:3410-3412
24. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005;18:553-559
25. Zhu DC, Penn RD. Full-brain T1 mapping through inversion recovery fast spin echo imaging with time-efficient slice ordering. Magn Reson Med 2005;54:725-731